When a patient faces a diagnosis of oral squamous cell carcinoma, doctors look for every possible tool to predict how the disease will progress. A new look at 30 different studies shows that a specific blood cell ratio can provide important clues. This ratio compares neutrophils, which are a type of white blood cell, to lymphocytes, which are another type of white blood cell.
Researchers found that a higher ratio of these cells before surgery is linked to a higher risk of poorer survival. Specifically, patients with a higher ratio showed lower rates of overall survival, disease-free survival, and disease-specific survival. While the data did not show a clear link to how long a patient lived without the cancer progressing, the connection to overall survival remains a strong signal.
Because this test uses common blood counts, it could serve as a low-cost way to help doctors predict a patient's outlook. However, it is important to note that the findings come from a limited number of studies. While the results are consistent, the small number of studies means the evidence is still developing.
